Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureYanjing Xia, Dengying Yan, Demei Xiao, Yuxiang Xia
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Bisphenol P triggers hepatic injury via gut microbiota dysbiosis-induced intestinal barrier disruption
10.1016/j.jenvman.2026.128773 · 2026
Oryzanol ameliorates MCD-induced metabolic dysfunction-associated steatohepatitis in mice via gut microbiota reprogramming and TLR4/NF-κB signaling suppression
10.1152/ajpgi.00190.2024 · 2025
Gut microbiota and neuroinflammation in acute liver failure and chronic liver disease
10.3390/metabo13060772 · 2023
Yak milk ameliorates chronic alcohol-induced brain injury in mice by modulating the gut microbiota and suppressing the TLR4/NF-κB pathway
10.1039/d5fo03000e · 2025
Toll-like receptor 4 inhibition by pyridostigmine is associated with a reduction in hypertension and inflammation in rat models of preeclampsia
10.1097/hjh.0000000000003911 · 2025
Targeting the TLR4/NF-κB pathway in β-amyloid-stimulated microglial cells: a possible mechanism that oxysophoridine exerts anti-oxidative and anti-inflammatory effects in an in vitro model of Alzheimer’s disease
10.1016/j.brainresbull.2021.07.019 · 2021
Dendrobine and Erianin alleviate inflammation-induced depressive-like behaviors by targeting phosphodiesterase 4B in adolescent mice
10.1016/j.phymed.2025.157230 · 2025
From gut to liver: exploring the crosstalk between gut-liver axis and oxidative stress in metabolic dysfunction-associated steatotic liver disease
10.1016/j.aohep.2025.101777 · 2025
Gut dysbiosis correction contributes to the hepatoprotective effects of Thymus quinquecostatus Celak extract against alcohol through the gut-liver axis
10.1039/d1fo01117k · 2021
Apolipoprotein A-I: potential protection against intestinal injury induced by dietary lipid
10.2147/jir.s468842 · 2024
LCA and 3-oxo-LCA mitigate dietary oxysterols-induced loss of barrier function in intestinal epithelial cells
10.1016/j.steroids.2026.109749 · 2026
Impact of micro- and nanoplastics on gastrointestinal diseases: recent advances
10.1016/j.ejim.2025.07.015 · 2025
Effects of cholesterol-lowering probiotics on non-alcoholic fatty liver disease in FXR gene knockout mice
10.3389/fnut.2023.1121203 · 2023
Gut microbiome in non-alcoholic fatty liver disease
2024
Microbiome-mediated crosstalk between T2DM and MASLD: a translational review focused on function
10.3389/fendo.2025.1677175 · 2025
Endotoxemia and platelets: 2 players of intrahepatic microthrombosis in NAFLD
10.1016/j.jacbts.2023.07.003 · 2024
Bovine colostrum-derived extracellular vesicles protect against non-alcoholic steatohepatitis by modulating gut microbiota and enhancing gut barrier function
10.1016/j.crfs.2025.101039 · 2025
Role of NLRP3 in the metabolism of bile acids and gut microbiota in CCl4-induced liver fibrosis
10.1128/spectrum.00148-25 · 2025
Mechanism of legionella pneumophila-induced liver injury via gut microbiota translocation under immunosuppression
10.1016/j.prp.2026.156456 · 2026
Hepatic injury and ileitis associated with gut microbiota dysbiosis in mice upon F-53B exposure
10.1016/j.envres.2024.118305 · 2024
Lipopolysaccharide, arbiter of the gut-liver axis, modulates hepatic cell pathophysiology in alcoholism
10.1002/ar.25562 · 2025
Niloticin binds to MD-2 to promote anti-inflammatory pathway activation in macrophage cells
10.1177/03946320221133017 · 2022
Blumeatin inhibits LPS-induced inflammation of TLR4/NF-κB signaling pathway via targeting TLR4/MD-2
10.1080/10286020.2025.2469690 · 2025
Metformin inhibits microglial activation-mediated Cuproptosis by modulating the TLR4/Myd88/NF-κB Signaling pathway in Parkinson’s disease
10.1007/s12035-025-05499-9 · 2025
Pectolinarin alleviates inflammatory injury in a lipopolysaccharide-induced pneumonia model by inhibition of the TLR4/MyD88/NF-κB pathway
10.1016/j.tice.2026.103429 · 2026
Aloperine suppresses LPS-induced macrophage activation through inhibiting the TLR4/NF-κB pathway
10.1007/s00011-019-01313-0 · 2020
Advances in understanding lipopolysaccharide-mediated hepatitis: mechanisms and pathological features
10.3390/cimb47020079 · 2025
Thyme (Thymus quinquecostatus Celak) polyphenol-rich extract (TPE) alleviates HFD-induced liver injury in mice by inactivating the TLR4/NF-κB Signaling pathway through the gut-liver Axis
10.3390/foods12163074 · 2023
Protective effects of microbiome-derived inosine on lipopolysaccharide-induced acute liver damage and inflammation in mice via mediating the TLR4/NF-κB pathway
10.1021/acs.jafc.1c01781 · 2021
Artemisia ordosica polysaccharide alleviated lipopolysaccharide-induced oxidative stress of broilers via Nrf2/Keap1 and TLR4/NF-κB pathway
10.1016/j.ecoenv.2021.112566 · 2021
Qingrequzhuo capsule alleviated methionine and choline deficient diet-induced nonalcoholic steatohepatitis in mice through regulating gut microbiota, enhancing gut tight junction and inhibiting the activation of TLR4/NF-κB signaling pathway
2022
Hepatocyte-conditional knockout of phosphatidylethanolamine binding protein 4 aggravated LPS/D-GalN-induced acute liver injury via the TLR4/NF-κB pathway
10.3389/fimmu.2022.901566 · 2022
Molecular mechanism of anti-inflammatory effects of the proteasome inhibitor MG-132 on con A-induced acute liver injury in mice
10.1016/j.rvsc.2023.01.021 · 2023
Enoxaparin sodium bone cement plays an anti-inflammatory immunomodulatory role by inducing the polarization of M2 macrophages
10.1186/s13018-023-03865-8 · 2023
Histone methyltransferase SMYD2 regulates the activation of hepatic stellate cells by activating TLR4 signaling
2025
10.12659/msm.931143
10.12659/msm.931143
Dendrobium officinale alleviates high-fat diet-induced nonalcoholic steatohepatitis by modulating gut microbiota
10.3389/fcimb.2023.1078447 · 2023
10.1007/s00203-026-04720-0
10.1007/s00203-026-04720-0
Hic-5 deficiency attenuates hepatic ischemia reperfusion injury through TLR4/NF-κB signaling pathways
10.1016/j.lfs.2020.117517 · 2020
10.1002/alz.71243
10.1002/alz.71243
Immunomodulatory and immunoregulatory nanomedicines for autoimmunity
10.1016/j.smim.2021.101535 · doi-reference
NF-κB/IL-6 axis drives impaired corneal wound healing in aqueous-deficient dry eye
10.3389/fimmu.2025.1684290 · doi-reference
S100A8/A9 in recurrent pregnancy loss: pathogenic mechanisms and therapeutic potential
10.1016/j.jri.2026.104938 · doi-reference
Starring role of toll-like receptor-4 activation in the gut-liver axis
10.4291/wjgp.v6.i4.99 · doi-reference
Effect of ginseng saponins on beta-amyloid-suppressed acetylcholine release from rat hippocampal slices
10.1055/s-2001-17366 · doi-reference
Multi-target pharmacological effects of Asiatic acid: advances in structural modification and novel drug delivery systems
10.3390/molecules30183688 · doi-reference
Dihydromyricetin: a review on identification and quantification methods, biological activities, chemical stability, metabolism and approaches to enhance its bioavailability
10.1016/j.tifs.2019.07.038 · doi-reference
Uptake and transport mechanism of dihydromyricetin across human intestinal Caco-2 cells
10.1111/1750-3841.14112 · doi-reference
Therapeutic potential of genistein: preclinical studies, clinical evidence, and nanotechnology application
10.2174/0929867329666221004124800 · doi-reference
Enhancing oral bioavailability and immunostimulatory activity of Glycyrrhiza uralensis polysaccharides through PLGA nanoparticle delivery system
10.1016/j.ijbiomac.2026.152254 · doi-reference
Plant-derived polyphenolic compounds: nanodelivery through polysaccharide-based systems to improve the biological properties
10.1080/10408398.2023.2245038 · doi-reference
Molecular and regenerative effects of platelet-rich plasma and related Hemocomponents in animal models of liver injury-a systematic review
10.3390/ijms27021013 · doi-reference
Therapeutic potential of phages in autoimmune liver diseases
10.1111/cei.13092 · doi-reference
Controversies in clinical trials for alcoholic hepatitis
10.1016/j.jhep.2017.09.013 · doi-reference
Natural polysaccharides as potential anti-fibrotic agents: a review of their progress
10.1016/j.lfs.2022.120953 · doi-reference
Preventive and therapeutic role of betaine in liver disease: a review on molecular mechanisms
10.1016/j.ejphar.2021.174604 · doi-reference
Pasteurella multocida causes liver injury in ducks by mediating inflammatory, apoptotic and autophagic pathways
10.1016/j.micpath.2023.106336 · doi-reference
Macrophage polarization and its role in liver disease
10.3389/fimmu.2021.803037 · doi-reference
Fatty liver disease - non alcoholic to metabolic - a transition of concepts!!
10.4103/jfmpc.jfmpc_1863_21 · doi-reference
Asiatic acid alleviates LPS-induced Pyroptosis and endoplasmic reticulum stress-mediated apoptosis via inhibiting the HMGB1/TLR4/NF-κB pathway in broiler hepatocytes
10.1111/jpn.14070 · doi-reference
Oudemansiella radicata polysaccharides alleviated LPS-induced liver damage via regulating TLR4/NF-κB and Bax/Bcl-2 signaling pathways
10.1016/j.ijbiomac.2024.137370 · doi-reference
Laminaria japonica fucoidan ameliorates cyclophosphamide-induced liver and kidney injury possibly by regulating Nrf2/HO-1 and TLR4/NF-κB signaling pathways
10.1002/jsfa.11602 · doi-reference
Eupatilin protects against isotretinoin induced hepatotoxicity through immunomodulation of TLR4/MyD88/TRAF6 and NF-κB/NrF2 pathways
10.1016/j.ejphar.2025.177920 · doi-reference
Dietary silymarin improves gut-liver health by enhancing intestinal barrier integrity and modulating TLR4/NF-κB and NLRP3-mediated inflammatory responses in Aeromonas hydrophila-infected grass carp
10.1016/j.fsi.2026.111135 · doi-reference
Gut microbiota regulates acute myeloid leukaemia via alteration of intestinal barrier function mediated by butyrate
10.1038/s41467-022-30240-8 · doi-reference
Dihydromyricetin alleviates non-alcoholic fatty liver disease by modulating gut microbiota and inflammatory Signaling pathways
10.4014/jmb.2406.06048 · doi-reference
Polysaccharides from Eucommia ulmoides Oliv. leaves could alleviate gut microbiota dysbiosis and mitigate chronic alcoholic intoxication in mice
10.1002/mnfr.70497 · doi-reference
HSYA ameliorates venous thromboembolism by depleting the formation of TLR4/NF-κB pathway-dependent neutrophil extracellular traps
10.1016/j.intimp.2024.113534 · doi-reference
A meta-analysis-based adverse outcome pathway for the male reproductive toxicity induced by microplastics and nanoplastics in mammals
10.1016/j.jhazmat.2023.133375 · doi-reference
Flavonoids and polycystic ovary syndrome
10.1039/d5fo04823k · doi-reference
Phillygenin inhibits neuroinflammation and promotes functional recovery after spinal cord injury via TLR4 inhibition of the NF-κB signaling pathway
10.1016/j.jot.2024.07.013 · doi-reference
Inhibition of IRAK4 by microbial trimethylamine blunts metabolic inflammation and ameliorates glycemic control
10.1038/s42255-025-01413-8 · doi-reference
Gut microbiome-brain-cirrhosis axis
10.1097/hep.0000000000000344 · doi-reference
Reproductive function in men affected by X-linked adrenoleukodystrophy/adrenomyeloneuropathy
10.1530/eje-11-0490 · doi-reference
Restoration of ethanol-induced bifidobacterium pseudocatenulatum depletion ameliorates alcohol-associated liver disease
10.1038/s41522-026-00913-z · doi-reference
Swertia chirayita ameliorates MAFLD by improving intestinal microenvironment and hepatic lipogenesis
10.1016/j.jep.2026.121471 · doi-reference
miRNA-ome plasma analysis unveils changes in blood-brain barrier integrity associated with acute liver failure in rats
10.1186/s12987-023-00484-7 · doi-reference
Investigating the expression of CD180, LY96, VCAM-1, and CSF2RB in the lipopolysaccharide response pathway across different liver cirrhosis etiologies
10.1007/s11033-025-10780-0 · doi-reference
Theaflavin-3,3′-digallate prevents alcoholic liver injury by suppressing hepatic TLR4/NF-κB signaling and modulating the gut-liver axis in mice
10.1016/j.jnutbio.2025.110031 · doi-reference
Poria cocos polysaccharide prevents alcohol-induced hepatic injury and inflammation by repressing oxidative stress and gut leakiness
10.3389/fnut.2022.963598 · doi-reference